Profusa Announces 1-for-75 Reverse Stock Split

Market Intelligence Analysis

AI-Powered
Why This Matters

Profusa, a digital health company, has announced a 1-for-75 reverse stock split, which may be a strategy to increase the company's stock price and improve its marketability, but could also be seen as a negative sign by investors if the company's fundamentals are weak.

Market Impact

Market impact analysis based on neutral sentiment with 70% confidence.

Sentiment
Neutral
AI Confidence
70%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

BERKELEY, California, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual’s biochemistry, today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a one-for-seventy-five (1:75) reverse stock split of its common st

Continue Reading
Full article on Yahoo Finance
Read Full Article
Original article published by Yahoo Finance on February 5, 2026.
Analysis and insights provided by AnalystMarkets AI.